At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 280 enrolled
Drug / intervention
botulinum toxin Type Abiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine
In Brief
A Phase 4 clinical trial evaluating botulinum toxin Type A for Migraine Disorders. Completed, enrolled 280 participants across 1 site.
Detailed Summary
This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Disorders
CountriesSouth Korea
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 2014
Enrollment StartJul 2014
Primary CompletionFeb 2015
TodayJul 2026
First PostedMay 26, 2014
Enrollment StartJul 1, 2014
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.1 years ago
Interventions
botulinum toxin Type Abiological
Botulinum toxin Type A injected across specific head and neck muscles on Day 0.